Similarly, in a study of epilepsy, hM3Dq was used to transfer PV-INs into the hippocampal epileptic foci, and CNO activation increased the firing rate of parvalbumin neurons and inhibited the firing rate of glutamatergic neurons, thereby alleviating epileptic seizures. The gene discussed is PVALB; the disease is epilepsy.